Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Endocrinology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Prempro

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Wyeth
Approval Status: Approved January 1998
Treatment Area: Hormone replacement therapy

General Information

Prempro has been cleared for marketing with a new, increased progestin dose. The new dose of Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) contains 0.625 mg Premarin (conjugated estrogens) and 5 mg medroxyprogesterone acetate. The previously approved dose contains 0.625 mg Premarin and 2.5 mg medroxyprogesterone acetate. The drug is approved for use as a combination estrogen and progestin hormone replacement therapy.

Side Effects

Common side effects may include nausea, breast tenderness, headaches, and abdominal pain.